News
Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.
The CBSE noted a significant increase in Type-2 diabetes among children over the past decade, adding that sugar constitutes ...
Growing demand for natural weight loss solutions drives the weight management supplements market across health-conscious consumer segments.
A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.
Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...
ORLANDO -- Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score ...
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...
With its purchase of Boston Pharmaceuticals' drug, GSK extends a streak of dealmaking it's undertaken to build a liver disease franchise.
In a late-stage clinical trial, Wegovy (semaglutide) significantly reduced liver inflammation and reversed scarring in people with the liver disease MASH. MASH is associated with obesity and type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results